Fig. 6
From: A novel gene signature based on five immune checkpoint genes predicts the survival of glioma
Clinical accuracy of the signature. a and c The overall survival of high- and low-signature group in TCGA and CGGA database, respectively. b and e Nomogram rating scale was constructed with clinicopathological characteristics and the signature according to TCGA and CGGA, respectively. c and f Predictive accuracy assessment of TCGA and CGGA, respectively